Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays

Clinical Immunology

Volumn 125, Issue 2, 2007, Pages 120-126

  Liu, Edwin ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibody; Autoimmunity; ELISA; Fluid phase; Radioassay; Radiobinding; Radioimmunoassay

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANTIBODY DETECTION; ANTIGEN SPECIFICITY; AUTOANTIGEN LABELING; AUTOANTIGEN TRANSCRIPTION; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; CELIAC DISEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID PHASE ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOASSAY; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 35248878595     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.08.005     Document Type: Short Survey

References (27)

1. Yu L., and Eisenbarth G.S. Humoral autoimmunity in type 1 diabetes: cellular, molecular and clinical immunology. In: Eisenbarth G.S. (Ed). Type 1 Diabetes: Molecular, Cellular and Clinical Immunology (2006). http://www.uchsc.edu/misc/diabetes/books.html (http://www.uchsc.edu/misc/diabetes/books.html, Ref Type: Electronic Citation)
2. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S.F., Payne F., Lowe C.E., Szeszko J.S., Hafler J.P., Zeitels L., Yang J.H., Vella A., Nutland S., Stevens H.E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L.J., Healy B., Burren O.S., Lam A.A., Ovington N.R., Allen J., Adlem E., Leung H.T., Wallace C., Howson J.M., Guja C., Ionescu-Tirgoviste C., Simmonds M.J., Heward J.M., Gough S.C., Dunger D.B., Wicker L.S., and Clayton D.G. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39 (2007) 857-864
3. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
4. Bottazzo G.F., Florin-Christensen A., and Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2 (1974) 1279-1283
5. Srikanta S., Ganda O.P., Jackson R.A., Gleason R.E., Kaldany A., Garovoy M.R., Milford E.L., Carpenter C.B., Soeldner J.S., and Eisenbarth G.S. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann. Intern. Med. 99 (1983) 320-326
6. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., and Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222 (1983) 1337-1339
7. Wilkin T., Palmer J., Bonifacio E., Diaz J.-L., and Kruse V. The first international workshop on the standardization on insulin autoantibodies. Diabetology 30 (1987) 676-677
8. Wilkin T., Palmer J., Kurtz A., Bonifacio E., and Diaz J.-L. The Second International Workshop on the Standardization of Insulin Autoantibody (IAA) measurement. Diabetology 31 (1988) 449-450
9. Williams A.J.K., Bingley P.J., Bonifacio E., Palmer J.P., and Gale E.A.M. A novel micro-assay for insulin autoantibodies. J. Autoimmun. 10 (1997) 473-478
10. Vardi P., Ziegler A.G., Matthews J.H., Dib S., Keller R.J., Ricker A.T., Wolfsdorf J.I., Herskowitz R.D., Rabizadeh A., Eisenbarth G.S., and Soeldner J.S. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabet. Care 11 (1988) 736-739
11. Karlsen A.E., Hagopian W.A., Petersen J.S., Boel E., Dyrberg T., Grubin C.E., Michelsen B.K., Madsen O.D., and Lernmark Å. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes 41 (1992) 1355-1359
12. Lan M.S., Lu J., Goto Y., and Notkins A.L. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 13 (1994) 505-514
13. Brooking H., Ananieva-Jordanova R., Arnold C., Amoroso M., Powell M., Betterle C., Zanchetta R., Furmaniak J., and Smith B.R. A sensitive non-isotopic assay for GAD65 autoantibodies. Clin. Chim. Acta 331 (2003) 55-59
14. Achenbach P., Koczwara K., Knopff A., Naserke H., Ziegler A.G., and Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J. Clin. Invest. 114 (2004) 589-597
15. Sblattero D., Berti I., Trevisiol C., Marzari R., Tommasini A., Bradbury A., Fasano A., Ventura A., and Not T. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am. J. Gastroenterol. 95 (2000) 1253-1257
16. Bonamico M., Tiberti C., Picarelli A., Mariani P., Rossi D., Cipolletta E., Greco M., Tola M.D., Sabbatella L., Carabba B., Magliocca F.M., Strisciuglio P., and Di Mario U. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am. J. Gastroenterol. 96 (2001) 1536-1540
17. Liu E., Li M., Bao F., Miao D., Rewers M.J., Eisenbarth G.S., and Hoffenberg E.J. Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J. Pediatr. 146 (2005) 494-499
18. Yu L., Wang J., O'Dell J.R., Oates J., Arend W.P., and Eisenbarth G.S. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. J. Rheumatol. 34 (2007) 734-739
19. Yu L., Wang J., O'Dell J.R., Oates J., Arend W.P., and Eisenbarth G.S. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. J. Rheumatol. 34 (2007) 734-739
20. Yamamoto A.M., Amoura Z., Johannet C., Jeronimo A.L., Campos H., Koutouzov S., Piette J.C., and Bach J.F. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Arthritis Rheum. 43 (2000) 689-698
21. Meager A., Visvalingam K., Peterson P., Moll K., Murumagi A., Krohn K., Eskelin P., Perheentupa J., Husebye E., Kadota Y., and Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3 (2006) e289
22. Czaja A.J., Shums Z., and Norman G.L. Nonstandard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity 37 (2004) 195-201
23. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., Chapman R.W., Cooksley W.G., Czaja A.J., Desmet V.J., Donaldson P.T., Eddleston A.L., Fainboim L., Heathcote J., Homberg J.C., Hoofnagle J.H., Kakumu S., Krawitt E.L., Mackay I.R., MacSween R.N., Maddrey W.C., Manns M.P., McFarlane I.G., Meyer zum Buschenfelde K.H., and Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 31 (1999) 929-938
24. Bogdanos D.P., Gilbert D., Bianchi I., Leoni S., Mitry R.R., Ma Y., Mieli-Vergani G., and Vergani D. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J. Autoimmune Dis. 1 (2004) 4
25. Ma Y., Gregorio G., Gaken J., Muratori L., Bianchi F.B., Mieli-Vergani G., and Vergani D. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J. Hepatol. 26 (1997) 1396-1402
26. Li Q.Z., Zhou J., Wandstrat A.E., Carr-Johnson F., Branch V., Karp D.R., Mohan C., Wakel E.K., and Olsen N.J. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin. Exp. Immunol. 147 (2007) 60-70
27. O'Connor K.C., McLaughlin K.A., De Jager P.L., Chitnis T., Bettelli E., Xu C., Robinson W.H., Cherry S.V., Bar-Or A., Banwell B., Fukaura H., Fukazawa T., Tenembaum S., Wong S.J., Tavakoli N.P., Idrissova Z., Viglietta V., Rostasy K., Pohl D., Dale R.C., Freedman M., Steinman L., Buckle G.J., Kuchroo V.K., Hafler D.A., and Wucherpfennig K.W. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 13 (2007) 211-217